fashion -WSS

fashion

author：comprehensive 2025-10-02 18:49:52 - browse：662

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readers respond to H5N1 and livestock movements, and more

WSS

Biotech stock slump in 2023: awaiting the turnaround

NVIDIA and Google execs on the future of AI and drug discovery

Big Tobacco's 'harm reduction': Is it for real, or a sham?

How AI helped researchers track recovery from depression

Why are Kaiser Permanente staff considering a strike?

Senate HELP committee spars over health care workforce policies

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Activists slam private health insurers over coverage restrictions

It's been 20 years since Dolly the sheep. Where's my clone?

In Memoriam: Notable people who died in 2023

Venture capitalist Bob Kocher on the state of digital health

How to save PrEP access — and even expand it

Senators: Long

Psychedelics group wrestles with new pharma identity

HIV vaccine remains elusive. Immunologists keep trying new ideas

Hepatitis C has a cure — but many Americans still lack access to it

How Vertex's cystic fibrosis drug is changing patients' lives

leisure time

Why are Kaiser Permanente staff considering a strike?

Emergency workers more likely to restrain Black patients: study

Experts study whether long Covid risk adds up with each reinfection

Microbiome research is starting to find links to chronic diseases

STAT Virtual Event: Putting AI to the Test

How AI helped researchers track recovery from depression

focus

focus

hotspot

entertainment